Showing results (1-10 of 924) with videos related to
Sort By:
Pageof 93
Circulation|June 3, 2004
Inflammation as a cardiovascular risk factorJames T Willerson, Paul M RidkerJournal of the American College of Cardiology|April 25, 2006
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patientsSotirios Tsimikas, James T Willerson, Paul M RidkerCurrent Opinion in Cardiology|February 20, 2015
Stem cell therapy for cardiovascular diseases: a progressive journeyJames T WillersonProgress in Cardiovascular Diseases|June 22, 2002
Systemic and local inflammation in patients with unstable atherosclerotic plaquesJames T WillersonClinical Cardiology|April 24, 2003
Connecting the role of C-reactive protein and statins in cardiovascular diseasePaul M RidkerCurrent Atherosclerosis Reports|December 11, 2012
Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates?Paul M RidkerCirculation Research|February 1, 2019
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of AtherothrombosisPaul M RidkerCirculation Research|February 4, 2016
From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionPaul M RidkerAmerican Heart Journal|June 24, 2004
High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefitPaul M RidkerTransactions of the American Clinical and Climatological Association|July 23, 2013
Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?Paul M RidkerPageof 93